all all. today. later morning good Mike Thanks hope voted will and have you I or
business our good quarter, grew and segments second recovery a to with report by revenue in results STERIS encouraging resilience such you services. COVID-XX the related which with sequential pleased our are exposure on of to organic constant for work total, associates. quarter In procedure benefited the currency to and in continued reflect basis. done be volumes We as from products We improve as substantially well and strength X% continued year-over-year during the the
Our but performance through quarter, sciences few in the details, consumables. the for XX% the particular in highlights grew its quarter. on touch I release strong of walks will second a Life continuing
growth anticipation the the of the difficult of teens in XX% and the lower to the is believe we consumables demand. production underlying dissect growth vaccine due COVID-XX growth pre-buying it's While in in rate quarter, the balance remained to
COVID-XX product sterilization we related volumes. AST do quarter our particular first segment year-over-year the in device maintaining X% difficult procedure-related from as percentage continued levels was year's revenue comparisons as for COVID-XX quarter beginning sterilization fourth benefiting uptick. levels quarter, significant of demand not of grew all in As science anticipate a life year, last fourth significant quarter has In the recovery medical growth consumables the Rebounding these from said we our perpetuity. as well
AST, business. expansions in expectations As prior in reflecting invest continue to we said for growth quarters, the long-term at our aggressively we capacity in this
shipments second service segment revenue anticipated. as revenue equipment in shipments basis. healthcare anticipated, be rebounded was and from year. with some XX% Both of down quarter declined levels quarter impacted consumables procedures the our while continued by disruption year-over-year, declining growing flat. versus improving on last quarter X% in to consumables nicely were Those As a first we year-over-year and but X% the segment Capital sequential the service
quarter more have orders As May and business orders in large either pleasantly procedure from you low the return normal in grown point escalating world. that be equipment were know in procedures to in a as uncertainty replacements. the see around or return pandemic months sequentially last improvement is to to about date we replacement there areas in into Like volumes. capital revenue our are to many significant a the in We October while from the sequentially through Capital motion we projects COVID-XX reflecting sequential break rebounding levels. year's see our to pleased to the coming appears space, surprised
have going in and in the forward experience parts our disruption a of what second half We the planning the significant in Europe of That next of we US procedure recent seen will months. said, six too It volumes procedure is in soon not year. tell declines Europe. are we to in
a any we surgical are revenue As anticipated the about second key half result planning from for year-over-year in sequential excluding result the acquisition. growth to revenue, in flat impact
some and with quite near-term. in portfolio difficult start second to If line normal year, trends, more we're improve levels is back limit to the coming pleased consider somewhat. and bottom predict. have operation our downside the While the the continue cost to pandemic in subsides, healthcare we to to capital growth risk the our of expect the situation procedures still We the greatest fluid recent half of will equipment percentage will which
we As haul. said the long, long all we this business manage for
in pandemic. changed. Similarly, we programs by were and in business expenses $X.X this our reflect quarter, approach for QX. for avoid layoffs to what million decline our care including those to to second during unpaid and to place to saw of pandemic of our due that programs the operations half support cost COVID-XX to fiscal or related in about people extra who approach, hard actions COVID-XX. Total has decision in that furloughs in paid We providing not worked putting our impacted for compensation those take were jobs Our furloughs people maintain investments and need
next and surgical expand ORI continue We've in We system. full generation tables several to suite operating year a our surgical to a new of invest and AST including new introduced footprint this R&D. lights, products room
footprint On efforts result new the infection our or launched prevention rapid in development for sterilizers others. new as indicators the the more We in our business, slowdown spending smaller do consequential R&D of we recently side biological steam our include pandemic. not among product of a expect and products
our people I Before commitment front to we pandemic. the customers again their of STERIS be the thank to open who heroes to continued on like Q&A, for this lines have to would
like global well pandemic positioning of come there is COVID-XX during in we out we the of the portfolio near-term While the uncertainty our the it. situation, when as as given
of capture Surgical long-term family. opportunity continue With bright. over announced the that, completing is to previously forward turn Q&A. by I'll for toward for future the the year that to believe the to stand people Key's additional call calendar We STERIS are open STERIS and welcoming look and acquisition working We to ready to to Key Julie